Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications
Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.
Journal: Journal of clinical psychopharmacology
Published: April 14, 2026
Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression.
Journal: Therapeutic advances in psychopharmacology
Published: February 18, 2026
Next-Step Treatment Options for Treatment-Resistant Depression: Insights From the Mayo Clinic Depression Center Panel.
Journal: The Journal of clinical psychiatry
Published: January 28, 2026
A Structured Consent Framework for Research of Electroconvulsive Therapy in Advanced Dementia: Consent Process for the ECT-AD Trial.
Journal: The journal of ECT
Published: October 14, 2025
Ketamine Reduces Suicidality-Associated Emergency Department Utilization in Patients With Treatment-Resistant Depression: A 6-Month Mirror-Image Study.
Journal: The Journal of clinical psychiatry
Published: September 18, 2025
Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine: An Observational Study.
Journal: The Journal of clinical psychiatry
Published: August 06, 2025
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis.
Journal: Therapeutic advances in psychopharmacology
Published: July 10, 2025
Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.
Journal: Palliative & supportive care
Published: April 22, 2025
Efficacy and Safety of Transcranial Direct Current Stimulation for Depression in Older Adults: A Systematic Review and Meta-Analysis of Mixed-Age Studies.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Published: February 25, 2025
Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression.
Journal: Journal of affective disorders
Published: January 29, 2025
Last Updated: 09/26/2026